Express Scripts sees $750 mln in spending on new cholesterol drugs
October 06, 2015 at 17:00 PM EDT
Oct 6 (Reuters) - Express Scripts Holding Co, the largest manager of prescription drug plans for U.S. employers and health plans, said it has reached deals to cover two costly new cholesterol drugs and expects to spend $750 million on them next year.